Antibacterial surface treatment for orthopaedic implants

International Journal of Molecular Sciences

Volumn 15, Issue 8, 2014, Pages 13849-13880

  Gallo, Jiri ^a   Holinka, Martin ^a   Moucha, Calin S ^b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Anti adhesive; Antibacterial; Antibacterial proteins; Biomaterial associated infection; Orthopaedic; Prosthetic joint infection; Silver; Smart surfaces; Surface treatment

Indexed keywords

ALBUMIN; ANTIINFECTIVE AGENT; BETA DEFENSIN 2; CHEMOKINE; CHITOSAN DERIVATIVE; COPPER ION; NANOCOATING; NANOFILM; NANOMATERIAL; POLYETHERETHERKETONE; POLYMER; POLYPEPTIDE ANTIBIOTIC AGENT; SELENIUM; SILVER NANOPARTICLE; TITANIUM DIOXIDE; VANCOMYCIN; ZINC ION; BIOMATERIAL;

ANTIBACTERIAL ACTIVITY; BACTERIOPHAGE; BACTERIUM ADHERENCE; BIOFILM; CHEMICAL MODIFICATION; DISINFECTION; HYDROGEL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; JOINT PROSTHESIS; MATERIAL COATING; MEDICAL TECHNOLOGY; ORTHOPEDIC IMPLANT; PERIPROSTHETIC JOINT INFECTION; REVIEW; SURFACE PROPERTY; BACTERIA; DRUG EFFECTS; HUMAN; ORTHOPEDICS; PROSTHESES AND ORTHOSES; PROSTHESIS-RELATED INFECTIONS;

ANTI-BACTERIAL AGENTS; BACTERIA; COATED MATERIALS, BIOCOMPATIBLE; HUMANS; ORTHOPEDICS; PROSTHESES AND IMPLANTS; PROSTHESIS-RELATED INFECTIONS; SURFACE PROPERTIES;

EID: 84925884621     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150813849     Document Type: Review

References (261)

1. Cats-Baril, W.; Gehrke, T.; Huff, K.; Kendoff, D.; Maltenfort, M.; Parvizi, J. International consensus on periprosthetic joint infection: Description of the consensus process. Clin. Orthop. Relat. Res. 2013, 471, 4065-4075.
2. Lentino, J.R. Prosthetic joint infections: Bane of orthopedists, challenge for infectious disease specialists. Clin. Infect. Dis. 2003, 36, 1157-1161.
3. Dale, H.; Hallan, G.; Hallan, G.; Espehaug, B.; Havelin, L.I.; Engesaeter, L.B. Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop. 2009, 80, 639-645.
4. Aggarwal, V.K.; Bakhshi, H.; Ecker, N.U.; Parvizi, J.; Gehrke, T.; Kendoff, D. Organism profile in periprosthetic joint infection: Pathogens differ at two arthroplasty infection referral centers in Europe and in the United States. J. Knee Surg. 2014, 10, doi:10.1055/s-0033-1364102.
5. Zmistowski, B.; Karam, J.A.; Durinka, J.B.; Casper, D.S.; Parvizi, J. Periprosthetic joint infection increases the risk of one-year mortality. J. Bone Jt. Surg. Am. 2013, 95, 2177-2184.
6. Kurtz, S.M.; Lau, E.; Watson, H.; Schmier, J.K.; Parvizi, J. Economic burden of periprosthetic joint infection in the United States. J. Arthroplast. 2012, 27, 61-65.
7. Illingworth, K.D.; Mihalko, W.M.; Parvizi, J.; Sculco, T.; McArthur, B.; el Bitar, Y.; Saleh, K.J. How to minimize infection and thereby maximize patient outcomes in total joint arthroplasty: A multicenter approach: AAOS exhibit selection. J. Bone Jt. Surg. Am. 2013, 95, e50.
8. An, Y.H.; Friedman, R.J. Prevention of sepsis in total joint arthroplasty. J. Hosp. Infect. 1996, 33, 93-108.
9. Humphreys, H. Surgical site infection, ultraclean ventilated operating theatres and prosthetic joint surgery: Where now? J. Hosp. Infect. 2012, 81, 71-72.
10. Zhang, S.Y.; Herman, M.; Ciancanelli, M.J.; de Diego, P.R.; Sancho-Shimizu, V.; Abel, L.; Casanova, J.L. TLR3 immunity to infection in mice and humans. Curr. Opin. Immunol. 2013, 25, 19-33.
11. Ziakas, P.D.; Prodromou, M.L.; el Khoury, J.; Zintzaras, E.; Mylonakis, E. The role of TLR4 896 A>G and 1196 C>T in susceptibility to infections: A review and meta-analysis of genetic association studies. PLoS One 2013, 8, e81047.
12. Navratilova, Z.; Gallo, J.; Mrazek, F.; Lostak, J.; Petrek, M. MBL2 gene variation affecting serum MBL is associated with prosthetic joint infection in Czech patients after total joint arthroplasty. Tissue Antigens 2012, 80, 444-451.
13. Malik, M.H.; Bayat, A.; Jury, F.; Kay, P.R.; Ollier, W.E. Genetic susceptibility to total hip arthroplasty failure-Positive association with mannose-binding lectin. J. Arthroplast. 2007, 22, 265-270.
14. Pruzansky, J.S.; Bronson, M.J.; Grelsamer, R.P.; Strauss, E.; Moucha, C.S. Prevalence of modifiable surgical site infection risk factors in hip and knee joint arthroplasty patients at an urban academic hospital. J. Arthroplast. 2014, 29, 272-276.
15. Aggarwal, V.K.; Tischler, E.H.; Lautenbach, C.; Williams, G.R., Jr.; Abboud, J.A.; Altena, M.; Bradbury, T.L.; Calhoun, J.H.; Dennis, D.A.; del Gaizo, D.J.; et al. Mitigation and education. J. Arthroplast. 2014, 29, 19-25.
16. Gristina, A.G.; Naylor, P.; Myrvik, Q. Infections from biomaterials and implants: A race for the surface. Med. Prog. Technol. 1988, 14, 205-224.
17. Busscher, H.J.; van der Mei, H.C. How do bacteria know they are on a surface and regulate their response to an adhering state? PLoS Pathog. 2012, 8, e1002440.
18. Costerton, W.; Veeh, R.; Shirtliff, M.; Pasmore, M.; Post, C.; Ehrlich, G. The application of biofilm science to the study and control of chronic bacterial infections. J. Clin. Investig. 2003, 112, 1466-1477.
19. Chen, Y.; Busscher, H.J.; van der Mei, H.C.; Norde, W. Statistical analysis of long-and short-range forces involved in bacterial adhesion to substratum surfaces as measured using atomic force microscopy. Appl. Environ. Microbiol. 2011, 77, 5065-5070.
20. Wang, Y.; Subbiahdoss, G.; de Vries, J.; Libera, M.; van der Mei, H.C.; Busscher, H.J. Effect of adsorbed fibronectin on the differential adhesion of osteoblast-like cells and Staphylococcus aureus with and without fibronectin-binding proteins. Biofouling 2012, 28, 1011-1021.
21. Wagner, C.; Aytac, S.; Hansch, G.M. Biofilm growth on implants: Bacteria prefer plasma coats. Int. J. Artif. Organs 2011, 34, 811-817.
22. Ribeiro, M.; Monteiro, F.J.; Ferraz, M.P. Infection of orthopedic implants with emphasis on bacterial adhesion process and techniques used in studying bacterial-material interactions. Biomatter 2012, 2, 176-194.
23. Chagnot, C.; Zorgani, M.A.; Astruc, T.; Desvaux, M. Proteinaceous determinants of surface colonization in bacteria: Bacterial adhesion and biofilm formation from a protein secretion perspective. Front. Microbiol. 2013, 4, doi:10.3389/fmicb.2013.00303.
24. Jenney, C.R.; Anderson, J.M. Adsorbed serum proteins responsible for surface dependent human macrophage behavior. J. Biomed. Mater. Res. 2000, 49, 435-447.
25. Thevenot, P.; Hu, W.; Tang, L. Surface chemistry influences implant biocompatibility. Curr. Top. Med. Chem. 2008, 8, 270-280.
26. Roach, P.; Eglin, D.; Rohde, K.; Perry, C.C. Modern biomaterials: A review-Bulk properties and implications of surface modifications. J. Mater. Sci. Mater. Med. 2007, 18, 1263-1277.
27. Wilson, C.J.; Clegg, R.E.; Leavesley, D.I.; Pearcy, M.J. Mediation of biomaterial-cell interactions by adsorbed proteins: A review. Tissue Eng. 2005, 11, 1-18.
28. Stoodley, P.; Ehrlich, G.D.; Sedghizadeh, P.P.; Hall-Stoodley, L.; Baratz, M.E.; Altman, D.T.; Sotereanos, N.G. Orthopaedic biofilm infections. Curr. Orthop. Pract. 2011, 22, 558-563.
29. Costerton, J.W.; Stewart, P.S.; Greenberg, E.P. Bacterial biofilms: A common cause of persistent infections. Science 1999, 284, 1318-1322.
30. Laverty, G.; Gorman, S.P.; Gilmore, B.F. Biomolecular mechanisms of staphylococcal biofilm formation. Future Microbiol. 2013, 8, 509-524.
31. Foster, T.J.; Geoghegan, J.A.; Ganesh, V.K.; Hook, M. Adhesion, invasion and evasion: The many functions of the surface proteins of Staphylococcus aureus. Nat. Rev. Microbiol. 2014, 12, 49-62.
32. Fux, C.A.; Costerton, J.W.; Stewart, P.S.; Stoodley, P. Survival strategies of infectious biofilms. Trends Microbiol. 2005, 13, 34-40.
33. Anderson, J.M.; Rodriguez, A.; Chang, D.T. Foreign body reaction to biomaterials. Semin. Immunol. 2008, 20, 86-100.
34. Gardner, A.B.; Lee, S.K.; Woods, E.C.; Acharya, A.P. Biomaterials-based modulation of the immune system. Biomed. Res. Int. 2013, 2013, doi:10.1155/2013/732182.
35. Harvey, A.G.; Hill, E.W.; Bayat, A. Designing implant surface topography for improved biocompatibility. Expert Rev. Med. Devices 2013, 10, 257-267.
36. Cohen, H.C.; Joyce, E.J.; Kao, W.J. Biomaterials selectively modulate interactions between human blood-derived polymorphonuclear leukocytes and monocytes. Am. J. Pathol. 2013, 182, 2180-2190.
37. Busscher, H.J.; van der Mei, H.C.; Subbiahdoss, G.; Jutte, P.C.; van den Dungen, J.J.; Zaat, S.A.; Schultz, M.J.; Grainger, D.W. Biomaterial-associated infection: Locating the finish line in the race for the surface. Sci. Transl. Med. 2012, 4, 153rv10.
38. Nish, S.; Medzhitov, R. Host defense pathways: Role of redundancy and compensation in infectious disease phenotypes. Immunity 2011, 34, 629-636.
39. Zimmerli, W.; Lew, P.D.; Waldvogel, F.A. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J. Clin. Investig. 1984, 73, 1191-1200.
40. Higgins, D.M.; Basaraba, R.J.; Hohnbaum, A.C.; Lee, E.J.; Grainger, D.W.; Gonzalez-Juarrero, M. Localized immunosuppressive environment in the foreign body response to implanted biomaterials. Am. J. Pathol. 2009, 175, 161-170.
41. Zimmerli, W.; Sendi, P. Pathogenesis of implant-associated infection: The role of the host. Semin. Immunopathol. 2011, 33, 295-306.
42. Berbari, E.F.; Osmon, D.R.; Lahr, B.; Eckel-Passow, J.E.; Tsaras, G.; Hanssen, A.D.; Mabry, T.; Steckelberg, J.; Thompson, R. The Mayo prosthetic joint infection risk score: Implication for surgical site infection reporting and risk stratification. Infect. Control Hosp. Epidemiol. 2012, 33, 774-781.
43. Engelsman, A.F.; Saldarriaga-Fernandez, I.C.; Nejadnik, M.R.; van Dam, G.M.; Francis, K.P.; Ploeg, R.J.; Busscher, H.J.; van der Mer, H.C. The risk of biomaterial-associated infection after revision surgery due to an experimental primary implant infection. Biofouling 2010, 26, 761-767.
44. Gastmeier, P.; Breier, A.C.; Brandt, C. Influence of laminar airflow on prosthetic joint infections: A systematic review. J. Hosp. Infect. 2012, 81, 73-78.
45. Merollini, K.M.; Zheng, H.; Graves, N. Most relevant strategies for preventing surgical site infection after total hip arthroplasty: Guideline recommendations and expert opinion. Am. J. Infect. Control 2013, 41, 221-226.
46. Cristina, M.L.; Spagnolo, A.M.; Sartini, M.; Panatto, D.; Gasparini, R.; Orlando, P.; Ottria, G.; Perdelli, F. Can particulate air sampling predict microbial load in operating theatres for arthroplasty? PLoS One 2012, 7, e52809.
47. Breier, A.C.; Brandt, C.; Sohr, D.; Geffers, C.; Gastmeier, P. Laminar airflow ceiling size: No impact on infection rates following hip and knee prosthesis. Infect. Control Hosp. Epidemiol. 2011, 32, 1097-1102.
48. Engesaeter, L.B.; Lie, S.A.; Espehaug, B.; Furnes, O.; Vollset, S.E.; Havelin, L.I. Antibiotic prophylaxis in total hip arthroplasty: Effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop. Scand. 2003, 74, 644-651.
49. Hawn, M.T.; Richman, J.S.; Vick, C.C.; Deierhoi, R.J.; Graham, L.A.; Henderson, W.G.; Itani, K.M. Timing of surgical antibiotic prophylaxis and the risk of surgical site infection. JAMA Surg. 2013, 148, 649-657.
50. Wang, J.; Zhu, C.; Cheng, T.; Peng, X.; Zhang, W.; Qin, H.; Zhang, X. A systematic review and meta-analysis of antibiotic-impregnated bone cement use in primary total hip or knee arthroplasty. PLoS One 2013, 8, e82745.
51. Andersson, A.E.; Bergh, I.; Karlsson, J.; Eriksson, B.I.; Nilsson, K. Traffic flow in the operating room: An explorative and descriptive study on air quality during orthopedic trauma implant surgery. Am. J. Infect. Control 2012, 40, 750-755.
52. Clyburn, T.A.; Evans, R.P.; Moucha, C.S.; Prokuski, L. Surgical site infection prevention: The operating room environment. Instr. Course Lect. 2011, 60, 565-574.
53. Hester, R.A.; Nelson, C.L.; Harrison, S. Control of contamination of the operative team in total joint arthroplasty. J. Arthroplast. 1992, 7, 267-269.
54. Hey, J.D.; Patel, M.S. Prevention and cure? Or: Is an ounce of prevention worth a pound of cure? J. Health Econ. 1983, 2, 119-138.
55. Corvec, S.; Portillo, M.E.; Pasticci, B.M.; Borens, O.; Trampuz, A. Epidemiology and new developments in the diagnosis of prosthetic joint infection. Int. J. Artif. Organs 2012, 35, 923-934.
56. Cataldo, M.A.; Petrosillo, N.; Cipriani, M.; Cauda, R.; Tacconelli, E. Prosthetic joint infection: Recent developments in diagnosis and management. J. Infect. 2010, 61, 443-448.
57. Tsaras, G.; Osmon, D.R.; Mabry, T.; Lahr, B.; St Sauveur, J.; Yawn, B.; Kurland, R.; Berbari, E.F. Incidence, secular trends, and outcomes of prosthetic joint infection: A population-based study, olmsted county, Minnesota, 1969-2007. Infect. Control Hosp. Epidemiol. 2012, 33, 1207-1212.
58. Dale, H.; Fenstad, A.M.; Hallan, G.; Havelin, L.I.; Furnes, O.; Overgaard, S.; Pedersen, A.B.; Kärrholm, J.; Garellick, G.; Pulkkinen, P.; et al. Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop. 2012, 83, 449-458.
59. Rasouli, M.R.; Maltenfort, M.G.; Purtill, J.J.; Hozack, W.J.; Parvizi, J. Has the rate of in-hospital infections after total joint arthroplasty decreased? Clin. Orthop. Relat. Res. 2013, 471, 3102-3111.
60. Bozic, K.J.; Ward, D.T.; Lau, E.C.; Chan, V.; Wetters, N.G.; Naziri, Q.; Odum, S.; Fehring, T.K.; Mont, M.A.; Gioe, T.J.; et al. Risk factors for periprosthetic joint infection following primary total hip arthroplasty: A case control study. J. Arthroplast. 2014, 29, 154-156.
61. Namba, R.S.; Inacio, M.C.; Paxton, E.W. Risk factors associated with deep surgical site infections after primary total knee arthroplasty: An analysis of 56,216 knees. J. Bone Jt. Surg. Am. 2013, 95, 775-782.
62. Everhart, J.S.; Altneu, E.; Calhoun, J.H. Medical comorbidities are independent preoperative risk factors for surgical infection after total joint arthroplasty. Clin. Orthop. Relat. Res. 2013, 471, 3112-3119.
63. Jamsen, E.; Nevalainen, P.; Eskelinen, A.; Huotari, K.; Kalliovalkama, J.; Moilanen, T. Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: A single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. J. Bone Jt. Surg. Am. 2012, 94, e101.
64. Van de Vosse, E.; van Dissel, J.T.; Ottenhoff, T.H. Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect. Dis. 2009, 9, 688-698.
65. Kause, A.; Odegard, J. The genetic analysis of tolerance to infections: A review. Front. Genet. 2012, 3, 262.
66. Stahelova, A.; Mrazek, F.; Smizansky, M.; Petrek, M.; Gallo, J. Variation in the IL1B, TNF and IL6 genes and individual susceptibility to prosthetic joint infection. BMC Immunol. 2012, 13, 25.
67. Ratner, B.D.; Schoen, F.J. The concept and assessment of biocompatibility. In Biomaterials Science: An Introduction to Materials in Medicine, 1. 3rd ed.; Ratner, B.D., Hoffman, A.S., Schoen, F.J., Lemons, J.E., Eds.; Elsevier: Amsterdam, The Netherlands, 2013; pp. 588-592.
68. Bernthal, N.M.; Stavrakis, A.I.; Billi, F.; Cho, J.S.; Kremen, T.J.; Simon, S.I.; Cheung, A.L.; Finerman, G.A.; Lieberman, J.R.; Adams, J.S.; et al. A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings. PLoS One 2010, 5, e12580.
69. Follmann, H.D.; Martins, A.F.; Gerola, A.P.; Burgo, T.A.; Nakamura, C.V.; Rubira, A.F.; Muniz, E.C. Antiadhesive and antibacterial multilayer films via layer-by-layer assembly of TMC/heparin complexes. Biomacromolecules 2012, 13, 3711-3722.
70. Neoh, K.G.; Kang, E.T. Combating bacterial colonization on metals via polymer coatings: Relevance to marine and medical applications. ACS Appl. Mater. Interfaces 2011, 3, 2808-2819.
71. Muszanska, A.K.; Rochford, E.T.; Gruszka, A.; Bastian, A.A.; Busscher, H.J.; Norde, W.; van der Mei, H.C.; Herrmann, A. Antiadhesive polymer brush coating functionalized with antimicrobial and rgd peptides to reduce biofilm formation and enhance tissue integration. Biomacromolecules 2014, 15, 2019-2026.
72. An, Y.H.; Stuart, G.W.; McDowell, S.J.; McDaniel, S.E.; Kang, Q.; Friedman, R.J. Prevention of bacterial adherence to implant surfaces with a crosslinked albumin coating in vitro. J. Orthop. Res. 1996, 14, 846-849.
73. Zhu, H.; Guo, Z.; Liu, W. Adhesion behaviors on superhydrophobic surfaces. Chem. Commun. (Camb.) 2014, 18, 3900-3913.
74. Stallard, C.P.; McDonnell, K.A.; Onayemi, O.D.; O'Gara, J.P.; Dowling, D.P. Evaluation of protein adsorption on atmospheric plasma deposited coatings exhibiting superhydrophilic to superhydrophobic properties. Biointerphases 2012, 7, 31.
75. Poncin-Epaillard, F.; Herry, J.M.; Marmey, P.; Legeay, G.; Debarnot, D.; Bellon-Fontaine, M.N. Elaboration of highly hydrophobic polymeric surface-A potential strategy to reduce the adhesion of pathogenic bacteria? Mater. Sci. Eng. C 2013, 33, 1152-1161.
76. Shida, T.; Koseki, H.; Yoda, I.; Horiuchi, H.; Sakoda, H.; Osaki, M. Adherence ability of Staphylococcus epidermidis on prosthetic biomaterials: An in vitro study. Int. J. Nanomed. 2013, 8, 3955-3961.
77. Singh, A.V.; Vyas, V.; Patil, R.; Sharma, V.; Scopelliti, P.E.; Bongiorno, G.; Podestà, A.; Lenardi, C.; Gade, W.N.; Milani, P. Quantitative characterization of the influence of the nanoscale morphology of nanostructured surfaces on bacterial adhesion and biofilm formation. PLoS One 2011, 6, e25029.
78. Ivanova, E.P.; Truong, V.K.; Wang, J.Y.; Berndt, C.C.; Jones, R.T.; Yusuf, I.I.; Peake, I.; Schmidt, H.W.; Fluke, C.; Barnes, D.; et al. Impact of nanoscale roughness of titanium thin film surfaces on bacterial retention. Langmuir 2010, 26, 1973-1982.
79. Truong, V.K.; Lapovok, R.; Estrin, Y.S.; Rundell, S.; Wang, J.Y.; Fluke, C.J.; Crawford, R.J.; Ivanova, E.P. The influence of nano-scale surface roughness on bacterial adhesion to ultrafine-grained titanium. Biomaterials 2010, 31, 3674-3683.
80. Pandit, V.; Zuidema, J.M.; Venuto, K.N.; Macione, J.; Dai, G.; Gilbert, R.J.; Kotha, S.P. Evaluation of multifunctional polysaccharide hydrogels with varying stiffness for bone tissue engineering. Tissue Eng. A 2013, 19, 2452-2463.
81. Zhao, C.; Li, X.; Li, L.; Cheng, G.; Gong, X.; Zheng, J. Dual functionality of antimicrobial and antifouling of poly(N-hydroxyethylacrylamide)/salicylate hydrogels. Langmuir 2013, 29, 1517-1524.
82. Zan, X.; Kozlov, M.; McCarthy, T.J.; Su, Z. Covalently attached, silver-doped poly(vinyl alcohol) hydrogel films on poly(L-lactic acid). Biomacromolecules 2010, 11, 1082-1088.
83. Drago, L.; Boot, W.; Dimas, K.; Malizos, K.; Hansch, G.M.; Stuyck, J.; Gawlitta, D.; Romanò, C.L. Does implant coating with antibacterial-loaded hydrogel reduce bacterial colonization and biofilm formation in vitro? Clin. Orthop. Relat. Res. 2014, doi:10.1007/s11999-014-3558-1.
84. Cheng, H.; Li, Y.; Huo, K.; Gao, B.; Xiong, W. Long-lasting in vivo and in vitro antibacterial ability of nanostructured titania coating incorporated with silver nanoparticles. J. Biomed. Mater. Res. A 2013, doi:10.1002/jbm.a.35019.
85. Gao, A.; Hang, R.; Huang, X.; Zhao, L.; Zhang, X.; Wang, L.; Tang, B.; Ma, S.; Chu, P.K. The effects of titania nanotubes with embedded silver oxide nanoparticles on bacteria and osteoblasts. Biomaterials 2014, 35, 4223-4235.
86. Mei, S.; Wang, H.; Wang, W.; Tong, L.; Pan, H.; Ruan, C.; Ma, Q.; Liu, M.; Yang, H.; Zhang, L.; et al. Antibacterial effects and biocompatibility of titanium surfaces with graded silver incorporation in titania nanotubes. Biomaterials 2014, 35, 4255-4265.
87. Dong, W.; Zhu, Y.; Zhang, J.; Lu, L.; Zhao, C.; Qin, L.; Li, Y. Investigation on the antibacterial micro-porous titanium with silver nano-particles. J. Nanosci. Nanotechnol. 2013, 13, 6782-6786.
88. Panacek, A.; Balzerova, A.; Prucek, R.; Ranc, V.; Vecerova, R.; Husickova, V.; Pechoušek, J.; Filip, J.; Zbořil, R.; Kvítek, L. Preparation, characterization and antimicrobial efficiency of Ag/PDDA-diatomite nanocomposite. Colloids Surf. B Biointerfaces 2013, 110, 191-198.
89. Kvitek, L.; Panacek, A.; Soukupova, J.; Kolar, M.; Vecerova, R.; Prucek, R.; Holecová, M.; Zbořil, R. Effect of surfactants and polymers on stability and antibacterial activity of silver nanoparticles (NPs). J. Phys. Chem. C 2008, 112, 5825-5834.
90. Knetsch, M.L.W.; Koole, L.H. New strategies in the development of antimicrobial coatings: The example of increasing usage of silver and silver nanoparticles. Polymers 2011, 3, 340-3
91. Koseki, H.; Asahara, T.; Shida, T.; Yoda, I.; Horiuchi, H.; Baba, K.; Osaki, M. Clinical and histomorphometrical study on titanium dioxide-coated external fixation pins. Int. J. Nanomed. 2013, 8, 593-599.
92. Haenle, M.; Fritsche, A.; Zietz, C.; Bader, R.; Heidenau, F.; Mittelmeier, W.; Gollwitzer, H. An extended spectrum bactericidal titanium dioxide (TiO2) coating for metallic implants: In vitro effectiveness against MRSA and mechanical properties. J. Mater. Sci. Mater. Med. 2011, 22, 381-387.
93. Yue, C.; Kuijer, R.; Kaper, H.J.; van der Mei, H.C.; Busscher, H.J. Simultaneous interaction of bacteria and tissue cells with photocatalytically activated, anodized titanium surfaces. Biomaterials 2014, 35, 2580-2587.
94. Holinka, J.; Pilz, M.; Kubista, B.; Presterl, E.; Windhager, R. Effects of selenium coating of orthopaedic implant surfaces on bacterial adherence and osteoblastic cell growth. Bone Jt. J. 2013, 95, 678-682.
95. Tran, P.A.; Webster, T.J. Selenium nanoparticles inhibit Staphylococcus aureus growth. Int. J. Nanomed. 2011, 6, 1553-1558.
96. Rodriguez-Valencia, C.; Lopez-Alvarez, M.; Cochon-Cores, B.; Pereiro, I.; Serra, J.; Gonzalez, P. Novel selenium-doped hydroxyapatite coatings for biomedical applications. J. Biomed. Mater. Res. A 2013, 101, 853-861.
97. Hans, M.; Erbe, A.; Mathews, S.; Chen, Y.; Solioz, M.; Mucklich, F. Role of copper oxides in contact killing of bacteria. Langmuir 2013, 29, 16160-16166.
98. Hoene, A.; Prinz, C.; Walschus, U.; Lucke, S.; Patrzyk, M.; Wilhelm, L.; Neumann, H.G.; Schlosser, M. In vivo evaluation of copper release and acute local tissue reactions after implantation of copper-coated titanium implants in rats. Biomed. Mater. 2013, 8, doi:10.1088/1748-6041/8/3/035009.
99. Elizabeth, E.; Baranwal, G.; Krishnan, A.G.; Menon, D.; Nair, M. ZnO nanoparticle incorporated nanostructured metallic titanium for increased mesenchymal stem cell response and antibacterial activity. Nanotechnology 2014, 25, doi:10.1088/0957-4484/25/11/115101.
100. Hu, H.; Zhang, W.; Qiao, Y.; Jiang, X.; Liu, X.; Ding, C. Antibacterial activity and increased bone marrow stem cell functions of Zn-incorporated TiO2 coatings on titanium. Acta Biomater. 2012, 8, 904-915.
101. Antoci, V., Jr.; Adams, C.S.; Parvizi, J.; Ducheyne, P.; Shapiro, I.M.; Hickok, N.J. Covalently attached vancomycin provides a nanoscale antibacterial surface. Clin. Orthop. Relat. Res. 2007, 461, 81-87.
102. Antoci, V., Jr.; King, S.B.; Jose, B.; Parvizi, J.; Zeiger, A.R.; Wickstrom, E.; Freeman, T.A.; Composto, R.J.; Ducheyne, P.; Shapiro, I.M.; et al. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J. Orthop. Res. 2007, 25, 858-866.
103. Walter, M.S.; Frank, M.J.; Satue, M.; Monjo, M.; Ronold, H.J.; Lyngstadaas, S.P.; Haugen, H.J. Bioactive implant surface with electrochemically bound doxycycline promotes bone formation markers in vitro and in vivo. Dent. Mater. 2014, 30, 200-214.
104. Chennell, P.; Feschet-Chassot, E.; Devers, T.; Awitor, K.O.; Descamps, S.; Sautou, V. In vitro evaluation of TiO2 nanotubes as cefuroxime carriers on orthopaedic implants for the prevention of periprosthetic joint infections. Int. J. Pharm. 2013, 455, 298-305.
105. Hickok, N.J.; Shapiro, I.M. Immobilized antibiotics to prevent orthopaedic implant infections. Adv. Drug Deliv. Rev. 2012, 64, 1165-1176.
106. Norowski, P.A.; Courtney, H.S.; Babu, J.; Haggard, W.O.; Bumgardner, J.D. Chitosan coatings deliver antimicrobials from titanium implants: A preliminary study. Implant Dent. 2011, 20, 56-67.
107. Chen, X.N.; Gu, Y.X.; Lee, J.H.; Lee, W.Y.; Wang, H.J. Multifunctional surfaces with biomimetic nanofibres and drug-eluting micro-patterns for infection control and bone tissue formation. Eur. Cells Mater. 2012, 24, 237-248.
108. Renoud, P.; Toury, B.; Benayoun, S.; Attik, G.; Grosgogeat, B. Functionalization of titanium with chitosan via silanation: Evaluation of biological and mechanical performances. PLoS One 2012, 7, e39367.
109. Tan, H.; Ma, R.; Lin, C.; Liu, Z.; Tang, T. Quaternized chitosan as an antimicrobial agent: Antimicrobial activity, mechanism of action and biomedical applications in orthopedics. Int. J. Mol. Sci. 2013, 14, 1854-1869.
110. Rapsch, K.; Bier, F.F.; Tadros, M.; von Nickisch-Rosenegk, M. Identification of antimicrobial peptides and immobilization strategy suitable for a covalent surface coating with biocompatible properties. Bioconjug. Chem. 2014, 25, 308-319.
111. Costa, F.; Carvalho, I.F.; Montelaro, R.C.; Gomes, P.; Martins, M.C. Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces. Acta Biomater. 2011, 7, 1431-1440.
112. Zheng, D.; Neoh, K.G.; Shi, Z.; Kang, E.T. Assessment of stability of surface anchors for antibacterial coatings and immobilized growth factors on titanium. J. Colloid Interface Sci. 2013, 406, 238-246.
113. Lopez-Leban, F.; Kiran, M.D.; Wolcott, R.; Balaban, N. Molecular mechanisms of RIP, an effective inhibitor of chronic infections. Int. J. Artif. Organs 2010, 33, 582-589.
114. Chen, F.; Gao, Y.; Chen, X.; Yu, Z.; Li, X. Quorum quenching enzymes and their application in degrading signal molecules to block quorum sensing-dependent infection. Int. J. Mol. Sci. 2013, 14, 17477-17500.
115. Bouchet, A.M.; Iannucci, N.B.; Pastrian, M.B.; Cascone, O.; Santos, N.C.; Disalvo, E.A.; Hollmann, A. Biological activity of antibacterial peptides matches synergism between electrostatic and non electrostatic forces. Colloids Surf. B 2014, 114, 363-371.
116. Li, B.; McKeague, A.L. Emerging ideas: Interleukin-12 nanocoatings prevent open fracture-associated infections. Clin. Orthop. Relat. Res. 2011, 469, 3262-3265.
117. Thallinger, B.; Prasetyo, E.N.; Nyanhongo, G.S.; Guebitz, G.M. Antimicrobial enzymes: An emerging strategy to fight microbes and microbial biofilms. Biotechnol. J. 2013, 8, 97-109.
118. Chua, P.H.; Neoh, K.G.; Kang, E.T.; Wang, W. Surface functionalization of titanium with hyaluronic acid/chitosan polyelectrolyte multilayers and RGD for promoting osteoblast functions and inhibiting bacterial adhesion. Biomaterials 2008, 29, 1412-1421.
119. Glinel, K.; Thebault, P.; Humblot, V.; Pradier, C.M.; Jouenne, T. Antibacterial surfaces developed from bio-inspired approaches. Acta Biomater. 2012, 8, 1670-1684.
120. He, T.; Chan, V. Covalent layer-by-layer assembly of polyethyleneimine multilayer for antibacterial applications. J. Biomed. Mater. Res. A 2010, 95, 454-464.
121. Fu, J.; Ji, J.; Fan, D.; Shen, J. Construction of antibacterial multilayer films containing nanosilver via layer-by-layer assembly of heparin and chitosan-silver ions complex. J. Biomed. Mater. Res. A 2006, 79, 665-674.
122. Zhou, B.; Li, Y.; Deng, H.; Hu, Y.; Li, B. Antibacterial multilayer films fabricated by layer-by-layer immobilizing lysozyme and gold nanoparticles on nanofibers. Colloids Surf. B 2014, 116, 432-438.
123. Huang, W.; Li, X.; Xue, Y.; Huang, R.; Deng, H.; Ma, Z. Antibacterial multilayer films fabricated by LBL immobilizing lysozyme and HTCC on nanofibrous mats. Int. J. Biol. Macromol. 2013, 53, 26-31.
124. Min, J.; Braatz, R.D.; Hammond, P.T. Tunable staged release of therapeutics from layer-by-layer coatings with clay interlayer barrier. Biomaterials 2014, 35, 2507-2517.
125. Rizzello, L.; Pompa, P.P. Nanosilver-based antibacterial drugs and devices: Mechanisms, methodological drawbacks, and guidelines. Chem. Soc. Rev. 2013, 7, 1501-1518.
126. Gottenbos, B.; van der Mei, H.C.; Klatter, F.; Grijpma, D.W.; Feijen, J.; Nieuwenhuis, P.; Busscher, H.J. Positively charged biomaterials exert antimicrobial effects on gram-negative bacilli in rats. Biomaterials 2003, 24, 2707-2710.
127. Yu, Q.; Cho, J.; Shivapooja, P.; Ista, L.K.; Lopez, G.P. Nanopatterned smart polymer surfaces for controlled attachment, killing, and release of bacteria. ACS Appl. Mater. Interfaces 2013, 5, 9295-9304.
128. Holzapfel, B.M.; Reichert, J.C.; Schantz, J.T.; Gbureck, U.; Rackwitz, L.; Nöth, U.; Jakob, F.; Rudert, M.; Groll, J.; Hutmacher, D.W. How smart do biomaterials need to be? A translational science and clinical point of view. Adv. Drug Deliv. Rev. 2013, 65, 581-603.
129. Parvizi, J.; Antoci, V., Jr.; Hickok, N.J.; Shapiro, I.M. Selfprotective smart orthopedic implants. Expert Rev. Med. Devices 2007, 4, 55-64.
130. Mastronardi, E.; Foster, A.; Zhang, X.; Derosa, M.C. Smart materials based on DNA aptamers: Taking aptasensing to the next level. Sensors 2014, 14, 3156-3171.
131. Ehrlich, G.D.; Stoodley, P.; Kathju, S.; Zhao, Y.; McLeod, B.R.; Balaban, N.; Hu, F.Z.; Sotereanos, N.G.; Costerton, J.W.; Stewart, P.S.; et al. Engineering approaches for the detection and control of orthopaedic biofilm infections. Clin. Orthop. Relat. Res. 2005, 437, 59-66.
132. Shchukin, D.G.; Mohwald, H. Self-repairing coatings containing active nanoreservoirs. Small 2007, 3, 926-943.
133. Shchukin, D.; Mohwald, H. Materials science. A coat of many functions. Science 2013, 341, 1458-1459.
134. Yilmaz, C.; Colak, M.; Yilmaz, B.C.; Ersoz, G.; Kutateladze, M.; Gozlugol, M. Bacteriophage therapy in implant-related infections: An experimental study. J. Bone Jt. Surg. Am. 2013, 95, 117-125.
135. Ratner, B.D.; Hoffman, A.S. Physicochemical surface modifications of materials used in medicine. In Biomaterials Science: An Introduction to Materials in Medicine; Ratner, B.D., Hoffman, A.S., Schoen, F.J., Lemons, J.E., Eds.; Academic Press (Elsevier): Waltham, MA, USA, 2013; pp. 259-276.
136. Daghighi, S.; Sjollema, J.; van der Mei, H.C.; Busscher, H.J.; Rochford, E.T. Infection resistance of degradable versus non-degradable biomaterials: An assessment of the potential mechanisms. Biomaterials 2013, 34, 8013-8017.
137. Campoccia, D.; Cangini, I.; Selan, L.; Vercellino, M.; Montanaro, L.; Visai, L.; Arciola, C.R. An overview of the methodological approach to the in vitro study of anti-infective biomaterials. Int. J. Artif. Organs 2012, 35, 800-816.
138. Stoodley, P.; Hall-Stoodley, L.; Costerton, B.; DeMeo, P.; Shirtliff, M.; Gawalt, E.; Kathju, S. Biofilms, biomaterials, and device-related infections. In Biomaterials Science: An Introduction to Materials in Medicine; Ratner, B.D., Hoffman, A.S., Schoen, F.J., Lemons, J.E., Eds.; Academic Press (Elsevier): Waltham, MA, USA, 2013; pp. 565-583.
139. Barros, J.; Grenho, L.; Manuel, C.M.; Ferreira, C.; Melo, L.F.; Nunes, O.C.; Monteiro, F.J.; Ferraz, M.P. A modular reactor to simulate biofilm development in orthopedic materials. Int. Microbiol. 2013, 16, 191-198.
140. Ludecke, C.; Jandt, K.D.; Siegismund, D.; Kujau, M.J.; Zang, E.; Rettenmayr, M.; Bossert, J.; Roth, M. Reproducible biofilm cultivation of chemostat-grown Escherichia coli and investigation of bacterial adhesion on biomaterials using a non-constant-depth film fermenter. PLoS One 2014, 9, e84837.
141. Zaborowska, M.; Welch, K.; Branemark, R.; Khalilpour, P.; Engqvist, H.; Thomsen, P.; Trobos, M. Bacteria-material surface interactions: Methodological development for the assessment of implant surface induced antibacterial effects. J. Biomed. Mater. Res. B Appl. Biomater. 2014, doi:10.1002/jbm.b.33179.
142. Campoccia, D.; Montanaro, L.; Arciola, C.R. A review of the biomaterials technologies for infection-resistant surfaces. Biomaterials 2013, 34, 8533-8554.
143. Rojo, L.; Barcenilla, J.M.; Vazquez, B.; Gonzalez, R.; San Roman, J. Intrinsically antibacterial materials based on polymeric derivatives of eugenol for biomedical applications. Biomacromolecules 2008, 9, 2530-2535.
144. Song, C.; Zheng, Y. Wetting-controlled strategies: From theories to bio-inspiration. J. Colloid Interface Sci. 2013, doi:10.1016/j.jcis.2013.10.067.
145. MacCallum, J.L.; Tieleman, D.P. Hydrophobicity scales: A thermodynamic looking glass into lipid-protein interactions. Trends Biochem. Sci. 2011, 36, 653-662.
146. Bieser, A.M.; Tiller, J.C. Mechanistic considerations on contact-active antimicrobial surfaces with controlled functional group densities. Macromol. Biosci. 2011, 11, 526-534.
147. Braem, A.; van Mellaert, L.; Mattheys, T.; Hofmans, D.; de Waelheyns, E.; Geris, L.; Anné, J.; Schrooten, J.; Vleugels, J. Staphylococcal biofilm growth on smooth and porous titanium coatings for biomedical applications. J. Biomed. Mater. Res. A 2013, doi:10.1002/jbm.a.34688.
148. Vadillo-Rodriguez, V.; Pacha-Olivenza, M.A.; Gonzalez-Martin, M.L.; Bruque, J.M.; Gallardo-Moreno, A.M. Adsorption behavior of human plasma fibronectin on hydrophobic and hydrophilic Ti6Al4V substrata and its influence on bacterial adhesion and detachment. J. Biomed. Mater. Res. A 2013, 101, 1397-1404.
149. Yeo, I.S.; Kim, H.Y.; Lim, K.S.; Han, J.S. Implant surface factors and bacterial adhesion: A review of the literature. Int. J. Artif. Organs 2012, 35, 762-772.
150. Lu, T.; Qiao, Y.; Liu, X. Surface modification of biomaterials using plasma immersion ion implantation and deposition. Interface Focus 2012, 2, 325-336.
151. Bacakova, L.; Filova, E.; Parizek, M.; Ruml, T.; Svorcik, V. Modulation of cell adhesion, proliferation and differentiation on materials designed for body implants. Biotechnol. Adv. 2011, 29, 739-767.
152. Badihi Hauslich, L.; Sela, M.N.; Steinberg, D.; Rosen, G.; Kohavi, D. The adhesion of oral bacteria to modified titanium surfaces: Role of plasma proteins and electrostatic forces. Clin. Oral Implants Res. 2013, 24, 49-56.
153. Dale, H.; Skramm, I.; Lower, H.L.; Eriksen, H.M.; Espehaug, B.; Furnes, O.; Skjeldestad, F.E.; Havelin, L.I.; Engesaeter, L.B. Infection after primary hip arthroplasty: A comparison of 3 Norwegian health registers. Acta Orthop. 2011, 82, 646-654.
154. Engesaeter, L.B.; Espehaug, B.; Lie, S.A.; Furnes, O.; Havelin, L.I. Does cement increase the risk of infection in primary total hip arthroplasty? Revision rates in 56,275 cemented and uncemented primary THAs followed for 0-16 years in the Norwegian Arthroplasty Register. Acta Orthop. 2006, 77, 351-358.
155. Anselme, K.; Davidson, P.; Popa, A.M.; Giazzon, M.; Liley, M.; Ploux, L. The interaction of cells and bacteria with surfaces structured at the nanometre scale. Acta Biomater. 2010, 6, 3824-3846.
156. Puckett, S.D.; Taylor, E.; Raimondo, T.; Webster, T.J. The relationship between the nanostructure of titanium surfaces and bacterial attachment. Biomaterials 2010, 31, 706-713.
157. Mitik-Dineva, N.; Wang, J.; Mocanasu, R.C.; Stoddart, P.R.; Crawford, R.J.; Ivanova, E.P. Impact of nano-topography on bacterial attachment. Biotechnol. J. 2008, 3, 536-544.
158. Mitik-Dineva, N.; Wang, J.; Truong, V.K.; Stoddart, P.; Malherbe, F.; Crawford, R.J.; Ivanova, E.P. Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus attachment patterns on glass surfaces with nanoscale roughness. Curr. Microbiol. 2009, 58, 268-273.
159. An, Y.H.; Bradley, J.; Powers, D.L.; Friedman, R.J. The prevention of prosthetic infection using a cross-linked albumin coating in a rabbit model. J. Bone Jt. Surg. Br. 1997, 79, 816-819.
160. Harris, L.G.; Tosatti, S.; Wieland, M.; Textor, M.; Richards, R.G. Staphylococcus aureus adhesion to titanium oxide surfaces coated with non-functionalized and peptide-functionalized poly(L-lysine)-grafted-poly(ethylene glycol) copolymers. Biomaterials 2004, 25, 4135-4148.
161. Foka, A.; Katsikogianni, M.G.; Anastassiou, E.D.; Spiliopoulou, I.; Missirlis, Y.F. The combined effect of surface chemistry and flow conditions on Staphylococcus epidermidis adhesion and ica operon expression. Eur. Cells Mater. 2012, 24, 386-402.
162. Leisner, M.; Kuhr, J.T.; Radler, J.O.; Frey, E.; Maier, B. Kinetics of genetic switching into the state of bacterial competence. Biophys. J. 2009, 96, 1178-1188.
163. Norman, T.M.; Lord, N.D.; Paulsson, J.; Losick, R. Memory and modularity in cell-fate decision making. Nature 2013, 503, 481-486.
164. Decuzzi, P.; Ferrari, M. Modulating cellular adhesion through nanotopography. Biomaterials 2010, 31, 173-179.
165. Carson, L.; Gorman, S.P.; Gilmore, B.F. The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli. FEMS Immunol. Med. Microbiol. 2010, 59, 447-455.
166. Siddiq, D.M.; Darouiche, R.O. New strategies to prevent catheter-associated urinary tract infections. Nat. Rev. Urol. 2012, 9, 305-314.
167. Borovicka, J.; Metheringham, W.J.; Madden, L.A.; Walton, C.D.; Stoyanov, S.D.; Paunov, V.N. Photothermal colloid antibodies for shape-selective recognition and killing of microorganisms. J. Am. Chem. Soc. 2013, 135, 5282-5285.
168. Gomes, J.; Grunau, A.; Lawrence, A.K.; Eberl, L.; Gademann, K. Bioinspired surfaces against bacterial infections. Chimia 2013, 67, 275-278.
169. Lemire, J.A.; Harrison, J.J.; Turner, R.J. Antimicrobial activity of metals: Mechanisms, molecular targets and applications. Nat. Rev. Microbiol. 2013, 11, 371-384.
170. Visai, L.; de Nardo, L.; Punta, C.; Melone, L.; Cigada, A.; Imbriani, M.; Arciola, C.R. Titanium oxide antibacterial surfaces in biomedical devices. Int. J. Artif. Organs 2011, 34, 929-946.
171. Moseke, C.; Gbureck, U.; Elter, P.; Drechsler, P.; Zoll, A.; Thull, R.; Ewald, A. Hard implant coatings with antimicrobial properties. J. Mater. Sci.-Mater. Med. 2011, 22, 2711-2720.
172. Chernousova, S.; Epple, M. Silver as antibacterial agent: Ion, nanoparticle, and metal. Angew. Chem. Int. Ed. Engl. 2013, 52, 1636-1653.
173. Mijnendonckx, K.; Leys, N.; Mahillon, J.; Silver, S.; van Houdt, R. Antimicrobial silver: Uses, toxicity and potential for resistance. Biometals 2013, 26, 609-621.
174. Fielding, G.A.; Roy, M.; Bandyopadhyay, A.; Bose, S. Antibacterial and biological characteristics of silver containing and strontium doped plasma sprayed hydroxyapatite coatings. Acta Biomater. 2012, 8, 3144-3152.
175. Noda, I.; Miyaji, F.; Ando, Y.; Miyamoto, H.; Shimazaki, T.; Yonekura, Y.; Miyazaki, M.; Mawatari, M.; Hotokebuchi, T. Development of novel thermal sprayed antibacterial coating and evaluation of release properties of silver ions. J. Biomed. Mater. Res. B Appl. Biomater. 2009, 89, 456-465.
176. Panacek, A.; Kolar, M.; Vecerova, R.; Prucek, R.; Soukupova, J.; Krystof, V.; Hamal, P.; Zboril, R.; Kvítek, L. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials 2009, 30, 6333-6340.
177. Grass, G.; Rensing, C.; Solioz, M. Metallic copper as an antimicrobial surface. Appl. Environ. Microbiol. 2011, 77, 1541-1547.
178. Petrini, P.; Arciola, C.R.; Pezzali, I.; Bozzini, S.; Montanaro, L.; Tanzi, M.C.; Speziale, P.; Visai, L. Antibacterial activity of zinc modified titanium oxide surface. Int. J. Artif. Organs 2006, 29, 434-442.
179. Elguindi, J.; Wagner, J.; Rensing, C. Genes involved in copper resistance influence survival of Pseudomonas aeruginosa on copper surfaces. J. Appl. Microbiol. 2009, 106, 1448-1455.
180. Hodgkinson, V.; Petris, M.J. Copper homeostasis at the host-pathogen interface. J. Biol. Chem. 2012, 287, 13549-13555.
181. Pelgrift, R.Y.; Friedman, A.J. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv. Drug Deliv. Rev. 2013, 65, 1803-1815.
182. Vargas-Reus, M.A.; Memarzadeh, K.; Huang, J.; Ren, G.G.; Allaker, R.P. Antimicrobial activity of nanoparticulate metal oxides against peri-implantitis pathogens. Int. J. Antimicrob. Agents 2012, 40, 135-139.
183. Zhao, L.; Chu, P.K.; Zhang, Y.; Wu, Z. Antibacterial coatings on titanium implants. J. Biomed. Mater. Res. B 2009, 91, 470-480.
184. Finke, B.; Polak, M.; Hempel, F.; Rebl, H.; Zietz, C.; Stranak, V.; Lukowski, G.; Hippler, R.; Bader, R.; Nebe, J.B.; et al. Antimicrobial potential of copper-containing titanium surfaces generated by ion implantation and dual high power impulse magnetron sputtering. Adv. Eng. Mater. 2012, 14, B224-B230.
185. Arenas, M.A.; Perez-Jorge, C.; Conde, A.; Matykina, E.; Hernandez-Lopez, J.M.; Perez-Tanoira, R.; de Damborenea, J.J.; Gómez-Barrena, E.; Esteba, J. Doped TiO2 anodic layers of enhanced antibacterial properties. Colloids Surf. B Biointerfaces 2013, 105, 106-112.
186. Xia, W.; Grandfield, K.; Hoess, A.; Ballo, A.; Cai, Y.; Engqvist, H. Mesoporous titanium dioxide coating for metallic implants. J. Biomed. Mater. Res. B Appl. Biomater. 2012, 100, 82-93.
187. Uhm, S.H.; Song, D.H.; Kwon, J.S.; Lee, S.B.; Han, J.G.; Kim, K.N. Tailoring of antibacterial Ag nanostructures on TiO2 nanotube layers by magnetron sputtering. J. Biomed. Mater. Res. B 2014, 102, 592-603.
188. Masse, A.; Bruno, A.; Bosetti, M.; Biasibetti, A.; Cannas, M.; Gallinaro, P. Prevention of pin track infection in external fixation with silver coated pins: Clinical and microbiological results. J. Biomed. Mater. Res. 2000, 53, 600-604.
189. Kakinuma, H.; Ishii, K.; Ishihama, H.; Honda, M.; Toyama, Y.; Matsumoto, M.; Aizawa, M. Antibacterial polyetheretherketone implants immobilized with silver ions based on chelate-bonding ability of inositol phosphate: Processing, material characterization, cytotoxicity, and antibacterial properties. J. Biomed. Mater. Res. A 2014, doi:10.1002/jbm.a.35157.
190. Wang, Q.; Webster, T.J. Nanostructured selenium for preventing biofilm formation on polycarbonate medical devices. J. Biomed. Mater. Res. A 2012, 100, 3205-3210.
191. Martynkova, G.S.; Valaskova, M. Antimicrobial nanocomposites based on natural modified materials: A review of carbons and clays. J. Nanosci. Nanotechnol. 2014, 14, 673-693.
192. Alt, V.; Bitschnau, A.; Osterling, J.; Sewing, A.; Meyer, C.; Kraus, R.; Meissner, S.A.; Wenisch, S.; Domann, E.; Schnettler, R. The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model. Biomaterials 2006, 27, 4627-4634.
193. Schmidmaier, G.; Lucke, M.; Wildemann, B.; Haas, N.P.; Raschke, M. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: A review. Injury 2006, 37, S105-S112.
194. Fei, J.; Liu, G.D.; Pan, C.J.; Chen, J.Y.; Zhou, Y.G.; Xiao, S.H.; Wang, Y.; Yu, H.J. Preparation, release profiles and antibacterial properties of vancomycin-loaded Ca-P coating titanium alloy plate. J. Mater. Sci. Mater. Med. 2011, 22, 989-995.
195. Neut, D.; Dijkstra, R.J.; Thompson, J.I.; van der Mei, H.C.; Busscher, H.J. A gentamicin-releasing coating for cementless hip prostheses-Longitudinal evaluation of efficacy using in vitro bio-optical imaging and its wide-spectrum antibacterial efficacy. J. Biomed. Mater. Res. A 2012, 100, 3220-3226.
196. Shi, X.; Wu, H.; Li, Y.; Wei, X.; Du, Y. Electrical signals guided entrapment and controlled release of antibiotics on titanium surface. J. Biomed. Mater. Res. A 2013, 101, 1373-1378.
197. Salwiczek, M.; Qu, Y.; Gardiner, J.; Strugnell, R.A.; Lithgow, T.; McLean, K.M.; Thissen, H. Emerging rules for effective antimicrobial coatings. Trends Biotechnol. 2013, 32, 82-90.
198. Friedman, A.; Friedman, J. New biomaterials for the sustained release of nitric oxide: Past, present and future. Expert Opin. Drug Deliv. 2009, 6, 1113-1122.
199. Yount, N.Y.; Yeaman, M.R. Emerging themes and therapeutic prospects for anti-infective peptides. Annu. Rev. Pharmacol. Toxicol. 2012, 52, 337-360.
200. Guilhelmelli, F.; Vilela, N.; Albuquerque, P.; Derengowski, L.D.; Silva-Pereira, I.; Kyaw, C.M. Antibiotic development challenges: The various mechanisms of action of antimicrobial peptides and of bacterial resistance. Front. Microbiol. 2013, 4, 353.
201. Haney, E.F.; Hancock, R.E. Peptide design for antimicrobial and immunomodulatory applications. Biopolymers 2013, 100, 572-583.
202. Dobson, A.J.; Purves, J.; Kamysz, W.; Rolff, J. Comparing selection on S. aureus between antimicrobial peptides and common antibiotics. PLoS One 2013, 8, e76521.
203. Kazemzadeh-Narbat, M.; Lai, B.F.; Ding, C.; Kizhakkedathu, J.N.; Hancock, R.E.; Wang, R. Multilayered coating on titanium for controlled release of antimicrobial peptides for the prevention of implant-associated infections. Biomaterials 2013, 34, 5969-5977.
204. Kazemzadeh-Narbat, M.; Kindrachuk, J.; Duan, K.; Jenssen, H.; Hancock, R.E.; Wang, R. Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections. Biomaterials 2010, 31, 9519-9526.
205. Forbes, S.; McBain, A.J.; Felton-Smith, S.; Jowitt, T.A.; Birchenough, H.L.; Dobson, C.B. Comparative surface antimicrobial properties of synthetic biocides and novel human apolipoprotein E derived antimicrobial peptides. Biomaterials 2013, 34, 5453-5464.
206. Holmberg, K.V.; Abdolhosseini, M.; Li, Y.; Chen, X.; Gorr, S.U.; Aparicio, C. Bio-inspired stable antimicrobial peptide coatings for dental applications. Acta Biomater. 2013, 9, 8224-8231.
207. Gao, G.; Lange, D.; Hilpert, K.; Kindrachuk, J.; Zou, Y.; Cheng, J.T.; Kazemzadeh-Narbat, M.; Yu, K.; Wang, R.; Straus, S.K.; et al. The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides. Biomaterials 2011, 32, 3899-3909.
208. Li, B.; Jiang, B.; Boyce, B.M.; Lindsey, B.A. Multilayer polypeptide nanoscale coatings incorporating IL-12 for the prevention of biomedical device-associated infections. Biomaterials 2009, 30, 2552-2558.
209. Pereira, C.S.; Thompson, J.A.; Xavier, K.B. AI-2-mediated signalling in bacteria. FEMS Microbiol. Rev. 2013, 37, 156-181.
210. Lui, L.T.; Xue, X.; Sui, C.; Brown, A.; Pritchard, D.I.; Halliday, N.; Winzer, K.; Howdle, S.M.; Fernandez-Trillo, F.; Krasnogor, N.; et al. Bacteria clustering by polymers induces the expression of quorum-sensing-controlled phenotypes. Nat. Chem. 2013, 5, 1058-1065.
211. Gomes, J.; Grunau, A.; Lawrence, A.K.; Eberl, L.; Gademann, K. Bioinspired, releasable quorum sensing modulators. Chem. Commun. (Camb.) 2013, 49, 155-157.
212. Brooks, J.L.; Jefferson, K.K. Staphylococcal biofilms: Quest for the magic bullet. Adv. Appl. Microbiol. 2012, 81, 63-87.
213. Kiran, M.D.; Giacometti, A.; Cirioni, O.; Balaban, N. Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors. Int. J. Artif. Organs 2008, 31, 761-770.
214. Chen, G.; Swem, L.R.; Swem, D.L.; Stauff, D.L.; O'Loughlin, C.T.; Jeffrey, P.D.; Bassler, B.L.; Hughson, F.M. A strategy for antagonizing quorum sensing. Mol. Cell 2011, 42, 199-209.
215. Ho, K.K.; Chen, R.; Willcox, M.D.; Rice, S.A.; Cole, N.; Iskander, G.; Kumar, N. Quorum sensing inhibitory activities of surface immobilized antibacterial dihydropyrrolones via click chemistry. Biomaterials 2013, 35, 2336-2345.
216. Bottcher, T.; Kolodkin-Gal, I.; Kolter, R.; Losick, R.; Clardy, J. Synthesis and activity of biomimetic biofilm disruptors. J. Am. Chem. Soc. 2013, 135, 2927-2930.
217. Gu, Y.; Zhang, W.; Wang, H.; Lee, W.Y. Chitosan surface enhances the mobility, cytoplasm spreading, and phagocytosis of macrophages. Colloids Surf. B Biointerfaces 2014, 117, 42-50.
218. Peng, Z.X.; Tu, B.; Shen, Y.; Du, L.; Wang, L.; Guo, S.R.; Tang, T.T. Quaternized chitosan inhibits icaA transcription and biofilm formation by Staphylococcus on a titanium surface. Antimicrob. Agents Chemother. 2011, 55, 860-866.
219. Tan, H.; Peng, Z.; Li, Q.; Xu, X.; Guo, S.; Tang, T. The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus. Biomaterials 2012, 33, 365-377.
220. Yang, C.C.; Lin, C.C.; Liao, J.W.; Yen, S.K. Vancomycin-chitosan composite deposited on post porous hydroxyapatite coated Ti6Al4V implant for drug controlled release. Mater. Sci. Eng. C 2013, 33, 2203-2212.
221. Banerjee, M.; Mallick, S.; Paul, A.; Chattopadhyay, A.; Ghosh, S.S. Heightened reactive oxygen species generation in the antimicrobial activity of a three component iodinated chitosan-silver nanoparticle composite. Langmuir 2010, 26, 5901-5908.
222. Costa, F.; Maia, S.; Gomes, P.; Martins, M.C. Characterization of hLF1-11 immobilization onto chitosan ultrathin films, and its effects on antimicrobial activity. Acta Biomater. 2014, doi:10.1016/j.actbio.2014.02.028.
223. Jennison, T.; McNally, M.; Pandit, H. Prevention of infection in external fixator pin sites. Acta Biomater. 2014, 10, 595-603.
224. Shi, Z.; Neoh, K.G.; Kang, E.T.; Wang, W. Antibacterial and mechanical properties of bone cement impregnated with chitosan nanoparticles. Biomaterials 2006, 27, 2440-2449.
225. Rizzello, L.; Cingolani, R.; Pompa, P.P. Nanotechnology tools for antibacterial materials. Nanomedicine (Lond.). 2013, 8, 807-821.
226. Taylor, E.; Webster, T.J. Reducing infections through nanotechnology and nanoparticles. Int. J. Nanomed. 2011, 6, 1463-1473.
227. Nair, L.S.; Laurencin, C.T. Nanofibers and nanoparticles for orthopaedic surgery applications. J. Bone Jt. Surg. Am. 2008, 90, 128-131.
228. Campoccia, D.; Montanaro, L.; Agheli, H.; Sutherland, D.S.; Pirini, V.; Donati, M.E.; Arciola, C.R. Study of Staphylococcus aureus adhesion on a novel nanostructured surface by chemiluminometry. Int. J. Artif. Organs 2006, 29, 622-629.
229. Lee, F.P.; Wang, D.J.; Chen, L.K.; Kung, C.M.; Wu, Y.C.; Ou, K.L.; Yu, C.H. Antibacterial nanostructured composite films for biomedical applications: Microstructural characteristics, biocompatibility, and antibacterial mechanisms. Biofouling 2013, 29, 295-305.
230. Montanaro, L.; Campoccia, D.; Arciola, C.R. Nanostructured materials for inhibition of bacterial adhesion in orthopedic implants: A minireview. Int. J. Artif. Organs 2008, 31, 771-776.
231. Wang, H.; Cheng, M.; Hu, J.; Wang, C.; Xu, S.; Han, C.C. Preparation and optimization of silver nanoparticles embedded electrospun membrane for implant associated infections prevention. ACS Appl. Mater. Interfaces 2013, 5, 11014-11021.
232. Lischer, S.; Korner, E.; Balazs, D.J.; Shen, D.; Wick, P.; Grieder, K.; Haas, D.; Heuberger, M.; Hegemann, D. Antibacterial burst-release from minimal Ag-containing plasma polymer coatings. J. R. Soc. Interface 2011, 8, 1019-1030.
233. Zhang, X.; Li, Z.; Yuan, X.; Cui, Z.; Bao, H.; Li, X.; Liu, Y.; Yang, X. Cytotoxicity and antibacterial property of titanium alloy coated with silver nanoparticle-containing polyelectrolyte multilayer. Mater. Sci. Eng. C 2013, 33, 2816-2820.
234. Song, J.; Jang, J. Antimicrobial polymer nanostructures: Synthetic route, mechanism of action and perspective. Adv. Colloid Interface Sci. 2014, 203, 37-50.
235. Marková, Z.; Šišková, K.; Filip, J.; Šafářová, K.; Prucek, R.; Panáček, A.; Kolář, M.; Zbořil, R. Chitosan-based synthesis of magnetically-driven nanocomposites with biogenic magnetite core, controlled silver size, and high antimicrobial activity. Green Chem. 2012, 14, 2550-2558.
236. Prucek, R.; Tucek, J.; Kilianova, M.; Panacek, A.; Kvitek, L.; Filip, J.; Kolář, M.; Tománková, K.; Zbořil, R. The targeted antibacterial and antifungal properties of magnetic nanocomposite of iron oxide and silver nanoparticles. Biomaterials 2011, 32, 4704-4713.
237. Panacek, A.; Kvitek, L.; Prucek, R.; Kolar, M.; Vecerova, R.; Pizurova, N.; Sharma, V.K.; Nevecna, T.; Zboril, R. Silver colloid nanoparticles: Synthesis, characterization, and their antibacterial activity. J. Phys. Chem. B 2006, 110, 16248-16253.
238. Bondarenko, O.; Ivask, A.; Kakinen, A.; Kurvet, I.; Kahru, A. Particle-cell contact enhances antibacterial activity of silver nanoparticles. PLoS One 2013, 8, e64060.
239. Agnihotri, S.; Mukherji, S.; Mukherji, S. Immobilized silver nanoparticles enhance contact killing and show highest efficacy: Elucidation of the mechanism of bactericidal action of silver. Nanoscale 2013, 5, 7328-7340.
240. Martinez-Gutierrez, F.; Boegli, L.; Agostinho, A.; Sanchez, E.M.; Bach, H.; Ruiz, F.; James, G. Anti-biofilm activity of silver nanoparticles against different microorganisms. Biofouling 2013, 29, 651-660.
241. Kose, N.; Otuzbir, A.; Peksen, C.; Kiremitci, A.; Dogan, A. A silver ion-doped calcium phosphate-based ceramic nanopowder-coated prosthesis increased infection resistance. Clin. Orthop. Relat. Res. 2013, 471, 2532-2539.
242. Della Valle, C.; Visai, L.; Santin, M.; Cigada, A.; Candiani, G.; Pezzoli, D.; Arciola, C.R.; Imbriani, M.; Chiesa, R. A novel antibacterial modification treatment of titanium capable to improve osseointegration. Int. J. Artif. Organs 2012, 35, 864-875.
243. Liu, Y.; Zheng, Z.; Zara, J.N.; Hsu, C.; Soofer, D.E.; Lee, K.S.; Siu, R.K.; Miller, L.S.; Zhang, X.; Carpenter, D.; et al. The antimicrobial and osteoinductive properties of silver nanoparticle/poly (DL-lactic-co-glycolic acid)-coated stainless steel. Biomaterials 2012, 33, 8745-8756.
244. Lan, M.Y.; Liu, C.P.; Huang, H.H.; Lee, S.W. Both enhanced biocompatibility and antibacterial activity in Ag-decorated TiO2 nanotubes. PLoS One 2013, 8, e75364.
245. Seil, J.T.; Webster, T.J. Antibacterial effect of zinc oxide nanoparticles combined with ultrasound. Nanotechnology 2012, 23, 495101.
246. Vishwakarma, V.; Josephine, J.; George, R.P.; Krishnan, R.; Dash, S.; Kamruddin, M.; Kalavathi, S.; Manoharan, N.; Tyagi, A.K.; Dayal, R.K. Antibacterial copper-nickel bilayers and multilayer coatings by pulsed laser deposition on titanium. Biofouling 2009, 25, 705-710.
247. Jan, T.; Iqbal, J.; Ismail, M.; Zakaullah, M.; Naqvi, S.H.; Badshah, N. Sn doping induced enhancement in the activity of ZnO nanostructures against antibiotic resistant S. aureus bacteria. Int. J. Nanomed. 2013, 8, 3679-3687.
248. Campoccia, D.; Montanaro, L.; Arciola, C.R. A review of the clinical implications of anti-infective biomaterials and infection-resistant surfaces. Biomaterials 2013, 34, 8018-8029.
249. Shirwaiker, R.A.; Samberg, M.E.; Cohen, P.H.; Wysk, R.A.; Monteiro-Riviere, N.A. Nanomaterials and synergistic low-intensity direct current (LIDC) stimulation technology for orthopedic implantable medical devices. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2013, 5, 191-204.
250. Wang, J.; Zhu, Y.; Bawa, H.K.; Ng, G.; Wu, Y.; Libera, M.; van der Mei, H.C.; Busscher, H.J.; Yu, X. Oxygen-generating nanofiber cell scaffolds with antimicrobial properties. ACS Appl. Mater. Interfaces 2011, 3, 67-73.
251. Gallo, P.M.; Gallucci, S. The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity. Front. Immunol. 2013, 4, 138.
252. Shtansky, D.V.; Gloushankova, N.A.; Bashkova, I.A.; Kharitonova, M.A.; Moizhess, T.G.; Sheveiko, A.N.; Kiryukhantsev-Korneev, F.V.; Petrzhik, M.I.; Levashov, E.A. Multifunctional Ti-(Ca, Zr)-(C, N, O, P) films for load-bearing implants. Biomaterials 2006, 27, 3519-3531.
253. Hardes, J.; von Eiff, C.; Streitbuerger, A.; Balke, M.; Budny, T.; Henrichs, M.P.; Hauschild, G.; Ahrens, H. Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J. Surg. Oncol. 2010, 101, 389-395.
254. Hussmann, B.; Johann, I.; Kauther, M.D.; Landgraeber, S.; Jager, M.; Lendemans, S. Measurement of the silver ion concentration in wound fluids after implantation of silver-coated megaprostheses: Correlation with the clinical outcome. BioMed Res. Int. 2013, 2013, 763096.
255. Tran, P.A.; Sarin, L.; Hurt, R.H.; Webster, T.J. Titanium surfaces with adherent selenium nanoclusters as a novel anticancer orthopedic material. J. Biomed. Mater. Res. A 2010, 93, 1417-1428.
256. Pishbin, F.; Mourino, V.; Flor, S.; Kreppel, S.; Salih, V.; Ryan, M.P.; Boccaccini, A.R. Electrophoretic deposition of gentamicin-loaded bioactive glass/chitosan composite coatings for orthopaedic implants. ACS Appl. Mater. Interfaces 2014, 6, 8796-8806.
257. Zhuang, J.; Gordon, M.R.; Ventura, J.; Li, L.; Thayumanavan, S. Multi-stimuli responsive macromolecules and their assemblies. Chem. Soc. Rev. 2013, 42, 7421-7435.
258. Furth, M.E.; Atala, A.; van Dyke, M.E. Smart biomaterials design for tissue engineering and regenerative medicine. Biomaterials 2007, 28, 5068-5073.
259. Schneider, G.F.; Decher, G. From "nano-bags" to "micro-pouches". Understanding and tweaking flocculation-based processes for the preparation of new nanoparticle-composites. Nano Lett. 2008, 8, 3598-3604.
260. Zhao, X.; Meng, G.; Han, F.; Li, X.; Chen, B.; Xu, Q.; Zhu, X.; Chu, Z.; Kong, M.; Huang, Q. Nanocontainers made of various materials with tunable shape and size. Sci. Rep. 2013, 3, 2238.
261. Grainger, D.W.; van der Mei, H.C.; Jutte, P.C.; van den Dungen, J.J.; Schultz, M.J.; van der Laan, B.F.; Zaat, S.A.; Busscher, H.J. Critical factors in the translation of improved antimicrobial strategies for medical implants and devices. Biomaterials 2013, 34, 9237-9243.